The Reinvention of Life Science RegOps: is AI changing play?
At Breakthrough 2025, independent regulatory expert Preeya Beczek moderated the panel debate, Regulatory Operations: Driving Progress and Preparing for the Future.
See where AI and automation drive the greatest time and cost savings.
At Breakthrough 2025, independent regulatory expert Preeya Beczek moderated the panel debate, Regulatory Operations: Driving Progress and Preparing for the Future.
At Breakthrough in Zurich, Felix Arellano, Global Head of Drug Safety at Roche, shared a candid and inspiring account of Roche’s multi-year journey to launch their next-generation safety system: Voyager.
Our recent webinar “Embracing a Modular Strategy for Accelerated Digital Transformation in Safety Case Intake” featured industry experts discussing how leading organizations are leveraging modular, GenAI-powered solutions to seamlessly future-proof their Safety operations and integrate cutting-edge technologies in months, not years.
Relive the most exciting moments, key insights, and groundbreaking discussions from Breakthrough 2025.
At Breakthrough 2025, Claudia Lehmann, Head of Global PSPV Operations at Boehringer Ingelheim, joined a user panel discussing the impact of NavaX, the powerful AI and machine learning engine which powers the platform.
At Breakthrough 2025, Roche’s Jorge Carmona Toscano will join a panel discussion on emerging IT strategies to maximize the value of data and bed in greater GenAI use.
At Breakthrough 2025, Hans van Leeuwen, Global Head of Regulatory Affairs Data & Systems at Astellas Pharma, will take part in a panel discussion on the pursuit of greater interoperability between Regulatory and Safety systems.
Are you eager to attend Breakthrough 2025 this March in Zurich but need to secure approval from your manager or team?
In anticipation of a rousing Breakthrough 2025, Regulatory consultant and panel session moderator Preeya Beczek sets out her hopes for this year’s event.
Steve Gens previews some of the new research findings he’ll come armed with to a discussion panel on the future of Regulatory operations in an AI automation context.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved